In human inflammatory disorders, omega-3s used as adjunct therapy improve clinical and biomarker profiles; in periodontitis, recent trials and syntheses report better healing and inflammatory readouts with supplementation alongside standard care, with MMP-9 outcomes variably included but directionally favorable in gingival fluids or local tissue [140,141]. Here, MMP9 is linked to periodontitis.